SCHEMBL30984028

SCHEMBL30984028

CC1(Oc2ccnc(NCc3ccccn3)c2N)CCC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 3/20 0.41
▸ MAOB P27338 3/20 0.41
▸ PGK1 P00558 1/20 0.41
▸ ATAD2 Q6PL18 1/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ LMNA P02545 2/20 0.38
▸ GFER P55789 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ EGFR P00533 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ AURKA O14965 1/20 0.36
▸ RPS6KB1 P23443 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30984085 0.86 PSMB1 (0.43) ALDH1A1LMNATSHRHTTEGFR
SCHEMBL30983967 0.85 RECQL (0.42) MAOAMAOBPGK1ATAD2KMT2A
SCHEMBL30983979 0.84 ATAD2 (0.46) MAOAMAOBPGK1ATAD2KMT2A
SCHEMBL31269407 0.82 CTSB (0.39) MAOAMAOBPGK1KMT2AALDH1A1
SCHEMBL30983904 0.81 KCNH2 (0.38) PGK1ALDH1A1HTTKDM4EHPGD
SCHEMBL30984080 0.72 CA1 (0.42) KMT2AALDH1A1LMNAGFERHTT
SCHEMBL30983985 0.71 CTSB (0.43) MAOAMAOBATAD2KMT2AALDH1A1
SCHEMBL30984268 0.70 HTT (0.48) PGK1ALDH1A1LMNAHTTEGFR
SCHEMBL30983830 0.68 HTT (0.51) ALDH1A1LMNAHTTEGFRKDM4E
SCHEMBL10874371 0.67 KDM4C (0.59) MAOAMAOBATAD2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback